Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1369534-96-2

Post Buying Request

1369534-96-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1369534-96-2 Usage

Type

Oxetane (cyclic ether with a three-membered ring)

Functional Group

4-bromophenoxy group

Applications

Building block in organic synthesis
Development of new materials
Pharmaceutical applications
Agrochemical applications

Unique Properties

Unique structure
Reactivity conducive to diverse applications

Safety Precautions

Handle with care
Adhere to safety guidelines
Minimize potential hazards

Check Digit Verification of cas no

The CAS Registry Mumber 1369534-96-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,9,5,3 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1369534-96:
(9*1)+(8*3)+(7*6)+(6*9)+(5*5)+(4*3)+(3*4)+(2*9)+(1*6)=202
202 % 10 = 2
So 1369534-96-2 is a valid CAS Registry Number.

1369534-96-2Relevant articles and documents

Mild C–C Bond Formation via Lewis Acid Catalyzed Oxetane Ring Opening with Soft Carbon Nucleophiles

Huang, Hai,Zhang, Tianyu,Sun, Jianwei

, p. 2668 - 2673 (2021)

Mild oxetane opening by soft carbon nucleophiles has been developed for efficient C?C bond formation. In the presence of LiNTf2 or TBSNTf2 as catalyst, silyl ketene acetals were found to be effective nucleophiles to generate a wide range of highly oxygenated molecules, which are key substructure in natural products like polyketides. Furthermore, intramolecular oxetane opening by a styrene-based carbon nucleophile via a Prins-type process was also achieved with Sc(OTf)3 as catalyst, leading to efficient formation of the useful 2,3-dihydrobenzo[b]oxepine skeleton.

CATHEPSIN K INHIBITOR AND APPLICATION THEREOF

-

Paragraph 0301, (2018/07/29)

The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.

INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK

-

Paragraph 0799, (2013/10/22)

The present invention relates to indole and indazole compounds of Formula (I) that activate 5′ adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1369534-96-2